BVI diversifies away from FMD vaccines

Andrew Madeswi
Andrew Madeswi

The Botswana Vaccine Institute (BVI) has embarked on a transformational journey of broadening its product portfolio by ushering into human health drugs and those for other animal diseases.

Since its inception 37 years ago, BVI has played an important role as the World Organisation for Animal Health (OIE) regional reference laboratory for Foot and Mouth Disease (FMD) for Sub Saharan Africa, making BVI as one of the only two such facilities in Africa and part of a Global Network of 12 reference and Collaborating Centres.

Recently appointed BVI managing director, Andrew Madeswi said the Institute is diversifying away from FMD vaccines as part of its portfolio diversification and growth.

Editor's Comment
A call for collaboration in Botswana’s media landscape

This call is both timely and crucial, as it reflects a growing need for unity and collaboration amongst media bodies to address pressing issues facing the nation.The theme of this year’s Press Freedom Day, “A Press for the Planet: Journalism in the Face of the Environmental Crisis,” resonates deeply with Batswana, particularly in light of the ongoing human and wildlife conflict. Botswana’s rich wildlife population is not only a national...

Have a Story? Send Us a tip
arrow up